Responsible Center: NASA JSC
Grant Monitor: Whitmire, Alexandra
Center Contact: alexandra.m.whitmire@nasa.gov
Unique ID: 12561
|
Solicitation / Funding Source: 2018 HERO 80JSC018N0001-Crew Health and Performance (FLAGSHIP, OMNIBUS). Appendix A-Flagship, Appendix B-Omnibus
Grant/Contract No.: 80NSSC19K1581
Project Type: GROUND
Flight Program:
TechPort: No |
No. of Post Docs: 0
No. of PhD Candidates: 0
No. of Master's Candidates: 0
No. of Bachelor's Candidates: 0
|
No. of PhD Degrees: 0
No. of Master's Degrees: 0
No. of Bachelor's Degrees: 0
|
Human Research Program Gaps: |
(1) BMed-102:Given exposures to spaceflight hazards (space radiation, isolation), how do we identify individual susceptibility, monitor molecular/biomarkers and acceptable thresholds, and validate behavioral health and CNS/neurological/neuropsychological performance measures and domains of relevance to exploration class missions? (2) BMed-103:What are the validated, efficacious treatments (individual or Team-based) and/or countermeasures to prevent adverse behavioral conditions, CNS/neurological, and/or psychiatric disorders caused by either single and/or integrated exposures to spaceflight hazards during exploration class missions? (3) BMed-105:Given the potentially negative spaceflight associated CNS/cognitive changes and behavioral experiences of stressors during long-duration missions (e.g., isolation, confinement, reduced sensory stimulation, altered gravity, space radiation), what are validated medical or dietary countermeasures to mitigate stressors impacting on CNS / cognition / behavioral health? (4) BMed-107:What are the long-term changes and risks to astronaut health post-mission that, when using a continuity of care model, helps retrospectively identify and understand individual susceptibility (e.g., hereditary, dose, thresholds) to mitigate adverse CNS, cognitive, and behavioral health changes resulting from long-duration exploration missions, promoting the behavioral health of current and future crews? (5) BMed-108:Given each crewmember will experience multiple spaceflight hazards simultaneously, we need to identify and characterize the potential additive, antagonistic, or synergistic impacts of multiple stressors (e.g., space radiation, altered gravity, isolation, altered immune, altered sleep) on crew health and/or CNS/ cognitive functioning to develop threshold limits and validate countermeasures for any identified adverse crew health and/or operationally-relevant performance outcomes. (6) SM-104:Evaluate how weightlessness-induced changes in sensorimotor/vestibular function relate to and/or interact with changes in other brain functions (sleep, cognition, attention).
|
Task Description: |
The purpose of this application is to: 1) determine the possible synergistic and individual effects of radiation exposure (GCRsim), isolation confinement stress, and altered gravity on behavioral, cognitive, and sensorimotor performance; 2) establish if there are sex-dimorphic responses; 3) develop predictive biomarkers for individual sensitivity; 4) incorporate these results into a predictive statistical model for the extrapolation of performance decrement; and 5) estimate Central Nervous System (CNS) risks in astronauts.
The central hypothesis of this proposal is that there is a synergistic effect of multiple factors (defined by GCRsim, isolation confinement stress, and altered gravity) encountered in deep space exposure that leads to enhanced inflammatory response, promotes synapse loss, and decreases synaptic integrity that leads to long-term loss of sensorimotor, behavioral, and cognitive functions.
The rationale of the proposed research is to understand the mechanisms that underlie the cumulative and synergistic effects of radiation exposure, isolation confinement stress, and altered gravity on behavioral, cognitive, and sensorimotor deficits. Further, we will explore sex-dimorphic responses along with potential peripheral biomarkers associated with simulated deep space travel. Our studies will provide novel information regarding the cellular mechanisms of altered neuronal function involved in simulated deep space conditions (GCRsim, isolation confinement, and altered gravity). Finally, we will incorporate all the results to build risk assessment and performance decrement for astronauts.
We will characterize molecular, cellular, tissue, and behavioral endpoints underlying CNS function in an individual manner with animals prescreening. We will use multiple behavioral and cognitive tests known to be comparable to human performance. We will use state of the art techniques to dissect cellular and molecular changes in the brain. The endpoints will be selected to probe key physiological processes that support tissue homeostasis plasticity in the brain. We will determine if and how cellular and molecular impairments are linked to compromised behavior in motor, social, and cognitive domains. By combining assessments of multiple processes that may have distinct time constants and magnitudes of responses to simulated deep space conditions we will begin to identify operationally-relevant brain functions impacted by the three stressors and relate these to human performance. Furthermore, by comparing outcome measures in both males and females we will begin to understand the distinct aspects of the responses controlled by sex and are therefore more likely to translate to humans.
The proposed aims directly address Human Exploration Research Opportunities (HERO) announcement needs detailed in Appendix A that specify research needs (gaps) related to NASA Research and Technology Development to Support Crew Health and Performance in Space Exploration Missions. The specific gaps this proposal addresses are Topic 1, gap CNS 1 (Are there significant adverse changes in CNS performance in the context and time scale of spaceflight operations? If so, how is significance defined, and which neuropsychological domains are affected? Is there a significant probability that space radiation exposure would result in adverse changes? What are the pathways and mechanisms of change?), CNS 2 (Does space radiation exposure elicit key events in adverse outcome pathways associated with neurological diseases? What are the key events or hallmarks, their time sequence and their associated biomarkers (in-flight or post-flight)?), CNS 5 (How can new knowledge and data from molecular, cellular, tissue and animal models of acute CNS adverse changes or clinical human data, including altered motor and cognitive function and behavioral changes be used to estimate acute CNS risks to astronauts from GCR and SPE-solar particle event?), SM6.1 (Determine if sensorimotor dysfunction during and after long-duration spaceflight affects ability to control spacecraft and associated systems), SM 26 (Determine if exposure to long-duration spaceflight leads to neural structural alterations and if this remodeling impacts cognitive and functional performance), and IM 8 (IM8: We do not know the influence, direct, or synergistic, on the immune system of other physiological changes associated with spaceflight). |